A decades-long foundation of public health is at risk as a CDC advisory panel, influenced by Health and Human Services Secretary Robert F. Kennedy Jr.’s vaccine skepticism, reconsiders the long-standing recommendation for the hepatitis B birth dose vaccine. Medical analysts are sounding the alarm, warning that any delay or elimination of this critical policy could reverse successful efforts to protect newborns from the serious, incurable virus and erode public trust in vital vaccination programs across the United States.
Story Highlights
- The CDC panel, influenced by RFK Jr., is reconsidering the hepatitis B birth dose vaccine.
- Medical analysts warn this could reverse decades of public health successes.
- RFK Jr.’s vaccine skepticism is causing concern among healthcare professionals.
- The decision could set a precedent for vaccine policy changes in the U.S.
RFK Jr.’s Influence on Vaccine Policy
The CDC’s Advisory Committee on Immunization Practices (ACIP) is facing scrutiny as it considers changes to the hepatitis B birth dose recommendation. Appointed by Health and Human Services Secretary Robert F. Kennedy Jr., the panel’s deliberations could disrupt a long-standing policy that has protected millions of newborns from hepatitis B. RFK Jr.’s history of vaccine skepticism, including debunked claims linking vaccines to autism, has fueled concerns about compromising public health safety.
The hepatitis B vaccine, implemented over 30 years ago, has been a critical tool in preventing disease transmission to infants. Medical analysts, including the American Academy of Pediatrics, emphasize its safety and effectiveness. They warn that any delay in vaccination could increase newborns’ vulnerability to hepatitis B, a virus that can cause severe liver disease and has no cure.
NEW: RFK Jr.'s handpicked CDC panel just voted to STOP recommending all newborns get vaccinated for hepatitis B.
Public health officials have warned AGAINST this. pic.twitter.com/Utwo4iBTT4
— First To Hear It (@firsttohearit) December 5, 2025
Potential Impact of Policy Change
Should the CDC panel vote to delay or eliminate the hepatitis B birth dose, immediate repercussions are expected. Lower vaccination rates could emerge as families become hesitant, potentially leaving infants unprotected during their most vulnerable stage. Additionally, healthcare providers might face confusion about vaccine administration, creating inconsistencies in care.
In the long term, decreased vaccine coverage would likely result in higher hepatitis B transmission rates across communities. This could lead to more individuals, especially newborns, suffering from chronic infections, cirrhosis, and liver cancer. Furthermore, altering this established policy might encourage similar challenges to other vital vaccination programs, undermining the integrity of public health infrastructure.
Medical Community’s Response
Medical professionals express grave concerns about the meeting’s potential to sow distrust in vaccines. Sean O’Leary of the American Academy of Pediatrics describes the session as a “disaster” that could erode confidence in established vaccines. Specalists argue that the scientific evidence overwhelmingly supports the safety and necessity of the hepatitis B birth dose.
While RFK Jr. and some ACIP members suggest that the hepatitis B vaccine is linked to autism, decades of research have consistently debunked these claims. The disease’s transmission through everyday items like razors and toothbrushes underscores the importance of vaccination in preventing its spread. The outcome of this vote will not only affect hepatitis B vaccination rates but also set a precedent for future vaccine policies in the U.S.
Watch the report: CDC panel to vote on Hepatitis B vaccine or newborns
Sources:
- Hepatitis B vaccine vote has medical world on edge
- CDC advisers delay vote on restricting infant hepatitis B vaccinations in tense meeting | Trump administration | The Guardian
- Not all babies need Hepatitis B vaccination at birth, says US health advisers
- U.S. advisory panel rolls back universal hepatitis B vaccine recommendation – National | Globalnews.ca
